A landmark review published in Biomolecules documenting GHK-Cus regulatory effects on over 4,000 human genes, including significant upregulation of collagen synthesis, anti-inflammatory pathways, and stem cell mobilization established the molecular basis for its clinical use
Schedule: Subcutaneous injections for 812 weeks (extend to 16 weeks if desired)
10.1016/S0070-2137(96)80007-0 Curr
For reconstitution math, injection technique, stacking protocols, and side effect data, see the complete GHK-Cu dosage guide
Plans that delay formulary addition should expect to start seeing formulary exception request submissions
Comparative Analysis of BPC 157 and BPC 159 in Tissue Regeneration